Cargando…
Immunotherapy in Combination with Well-Established Treatment Strategies in Pancreatic Cancer: Current Insights
Pancreatic ductal adenocarcinoma (PDAC) is the most common type of pancreatic cancer and fourth most common cause of death in developed countries. Despite improved survival rates after resection combined with adjuvant chemotherapy or neoadjuvant chemotherapy, recurrence still occurs in a high percen...
Autores principales: | Kole, Christo, Charalampakis, Nikolaos, Tsakatikas, Sergios, Frountzas, Maximos, Apostolou, Konstantinos, Schizas, Dimitrios |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8921671/ https://www.ncbi.nlm.nih.gov/pubmed/35300059 http://dx.doi.org/10.2147/CMAR.S267260 |
Ejemplares similares
-
Immunotherapy for Hepatocellular Carcinoma: A 2021 Update
por: Kole, Christo, et al.
Publicado: (2020) -
Hereditary Diffuse Gastric Cancer: A 2022 Update
por: Kole, Christo, et al.
Publicado: (2022) -
Upper Gastrointestinal Cancer Management in the COVID-19 Era: Risk of Infection, Adapted Role of Endoscopy, and Potential Treatment Algorithm Alterations
por: Apostolou, Konstantinos, et al.
Publicado: (2020) -
Could nutritional and functional status serve as prognostic factors for COVID-19 in the elderly?
por: Lidoriki, Irene, et al.
Publicado: (2020) -
The Impact of Trophoblast Cell-Surface Antigen 2 Expression on the Survival of Patients with Gastrointestinal Tumors: A Systematic Review
por: Liatsou, Efstathia, et al.
Publicado: (2023)